Mid Cap
Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price | Price change % | |
|---|---|---|---|---|---|
 1 Revolution Medicines RVMD $7.9B | $7.9B | $47.32 | +2.58% | ||
 2 Repligen RGEN $7.66B | $7.66B | $136.71 | -1.68% | ||
 3 Exelixis EXEL $7.6B | $7.6B | $26.66 | +1.6% | ||
 4 Halozyme HALO $7.5B | $7.5B | $59.18 | -2.07% | ||
 5 Krystal Biotech KRYS $5.09B | $5.09B | $177.11 | +0.67% | ||
 6 ADMA Biologics ADMA $4.73B | $4.73B | $20.29 | +3.68% | ||
 7 Immunovant IMVT $4.47B | $4.47B | $30.51 | +4.2% | ||
 8 Arcellx ACLX $4.21B | $4.21B | $78.23 | +2.66% | ||
 9 Denali Therapeutics DNLI $4.1B | $4.1B | $28.63 | +1.45% | ||
 10 CRISPR Therapeutics CRSP $3.86B | $3.86B | $45.37 | +1.05% | ||
 11 Iovance Biotherapeutics IOVA $3.17B | $3.17B | $10.46 | +7.17% | ||
 12 Apogee Therapeutics APGE $3.09B | $3.09B | $54.48 | -4.17% | ||
 13 Kymera Therapeutics KYMR $2.78B | $2.78B | $43.06 | -0.81% | ||
 14 Twist Bioscience TWST $2.54B | $2.54B | $43.34 | +1.29% | ||
 15 CG Oncology CGON $2.46B | $2.46B | $36.63 | +1.86% | ||
 16 SpringWorks Therapeutics SWTX $2.42B | $2.42B | $32.64 | +2.54% | ||
 17 ImmunityBio IBRX $2.39B | $2.39B | $3.43 | +0.88% | ||
 18 Neumora Therapeutics NMRA $2.36B | $2.36B | $14.76 | +8.93% | ||
 19 Novavax NVAX $2.18B | $2.18B | $13.61 | -5.62% | ||
 20 Vericel Corp VCEL $2.11B | $2.11B | $43.36 | +4.86% |